How Will The mRNA Cancer Vaccines And Therapeutics Market Expand At A CAGR Of 15.2% Through 2029?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Predicted Market Size Of The mRNA Cancer Vaccines And Therapeutics Industry By 2029?
In recent times, there has been a swift expansion in the market size for mRNA cancer vaccines and therapeutics. The market, which is projected to escalate from $61.52 billion in 2024 to $71.22 billion in 2025, will witness a compound annual growth rate (CAGR) of 15.8%. Factors that have contributed to this growth during the historic period include changing lifestyles, supportive funding, a propitious regulatory framework, a robust healthcare setup, and increased pipeline development.
Over the next several years, the mRNA cancer vaccines and therapeutics market is anticipated to undergo swift expansion. Projected to reach a value of $125.56 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%, this growth can largely be connected to factors such as positive clinical trial outcomes, increasing knowledge and acceptance of mRNA technology, unsatisfied needs in cancer care, the potential to enhance patient results and the possibility of off-the-shelf availability. Primary influential trends during the forecast period encompass broadening into new therapeutic domains, personalizing medical treatment, advancing mRNA delivery systems, multivalent mRNA vaccines and application of artificial intelligence and machine learning in mRNA design.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
Which Factors Are Steering Growth In The mRNA Cancer Vaccines And Therapeutics Market?
The escalating occurrence of cancer is predicted to stimulate expansion in the mRNA cancer vaccine and therapeutic market. Cancer refers to a range of diseases marked by uncontrolled growth and spread of abnormal cells that harm and kill normal bodily tissues. This rising trend of cancer can be attributed to inactive lifestyles, poor dietary choices, and exposure to environmental pollutants. mRNA cancer vaccines and treatments are critical in cancer management as they provide individualized, focused interventions that enhance the immune system’s capabilities to detect and combat cancerous cells, thereby improving the success rate of treatments and patient prognosis. For example, data from the American Cancer Society, a non-profit organization committed to eradicating cancer, showed that the projected number of newly diagnosed cancer cases in the United States rose from approximately 1,918,030 in 2022 to 1,958,310 in 2023. With breast cancer incidence leading the chronic conditions in the United States, the number of cases surged from 287,850 in 2022 to 297,790 in 2023. Hence, the increasing incidence of cancer is fueling the expansion of the mRNA cancer vaccine and therapeutics market.
What Are The Primary Segmentation Parameters In The mRNA Cancer Vaccines And Therapeutics Market?
The mrna cancer vaccines and therapeutics market covered in this report is segmented –
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
Which Emerging Trends Are Reshaping The mRNA Cancer Vaccines And Therapeutics Market Landscape?
The mRNA cancer vaccine and therapeutics market is dominated by major industry players who are concentrating on developing innovative solutions like mRNA cancer vaccines to increase effectiveness, improve patient prognosis and meet the escalating need for potent cancer treatments. mRNA cancer vaccines belong to the immunotherapy category, utilizing messenger RNA to direct cells to create specific antigens, which boosts the immune system to identify and combat cancer cells. For instance, in May 2024, a biotech company from China, WestGene Biopharma, received FDA approval for a new investigational drug application of its mRNA cancer therapeutic vaccine, WGc-043. This approval by the FDA of WGc-043 represents a significant stride in dealing with advanced EB virus-associated cancers, closely connected to more than ten types of cancer, including nasopharyngeal carcinoma, NK T-cell lymphoma, and cancers of the stomach, lung, liver, esophagus, breast, and cervix, as well as autoimmune disorders like multiple sclerosis and lupus.
Which Organizations Are At The Forefront Of The mRNA Cancer Vaccines And Therapeutics Market?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For mRNA Cancer Vaccines And Therapeutics Market Expansion?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
